NCT04850937View on ClinicalTrials.gov

Effect of Low-dose Esketamine on Postoperative Depression in Patients With Breast Cancer

NACompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

February 10, 2021

Primary Completion Date

April 10, 2021

Study Completion Date

May 10, 2022

Conditions
Depression
Interventions
DRUG

Esketamine

The experimental group will be given 0.25mg/kg esketamine slowly intravenously after anesthesia induction

DRUG

normal saline

The experimental group will be given 0.5ml/kg normal saline intravenously after anesthesia induction

Trial Locations (1)

225100

Affiliated hospital of yangzhou university, Yangzhou

All Listed Sponsors
lead

Yangzhou University

OTHER

NCT04850937 - Effect of Low-dose Esketamine on Postoperative Depression in Patients With Breast Cancer | Biotech Hunter | Biotech Hunter